| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 2002;123:919-927
© 2002 The American Association for Thoracic Surgery
Surgery for Acquired Cardiovascular Disease (ACD) |
From the Divisions of Cardiac Surgerya and Cardiology,b Herzzentrum, University of Leipzig, Leipzig, Germany.
Received for publication May 15, 2001. Revisions requested June 25, 2001; revisions received Aug 2, 2001. Accepted for publication Aug 8, 2001. Address for reprints: Friedrich W. Mohr, MD, PhD, Abteilung für Herzchirurgie, Herzzentrum Leipzig, Russenstrasse 19, D-04289 Leipzig, Germany (E-mail: mohrf{at}medizin.uni-leipzig.de).
 |
Abstract |
|---|
 Top Abstract IntroductionResultsDiscussionAppendix: DiscussionReferences |
|---|
|
Introduction |
|---|
|
TopAbstractIntroductionResultsDiscussionAppendix: DiscussionReferences |
|---|
1,2 A number of interventional concepts that are based on eliminating the initiating trigger or modifying the maintaining substrate have evolved within the past 2 decades. Catheter-based interventions for ventricular rate control, such as atrioventricular junction ablation or atrioventricular nodal modification, have the disadvantage of persistence of AF. 3 Surgical techniques such as the corridor operation 4 or left atrial isolation 5 effectively restore sinus rhythm but not biatrial transport function. The maze procedure 6,7 and the so-called radial approach, 8,9 although highly effective, are technically demanding and time consuming, and they therefore have not found widespread application outside a few centers of excellence.
Percutaneous radiofrequency ablation to induce right atrial lesions for the treatment of paroxysmal AF has shown to be feasible. 10 However, the reported success rates were only 13% if only the right atrium was ablated and 44% to 47% if additional lines were made in the left atrium, potentially replicating the maze concept. 11,12 For the treatment of idiopathic AF, catheter-based radiofrequency ablation has shown poor results. One hundred percent of all patients who underwent ablation confined to the left atrium had recurrence of AF 13 as a result of technical difficulties that prevented the creation of the intended left atrial line pattern. In right atrial ablation, recurrence was 94% despite creation of complete line patterns in the right atrium in half of the treated patients. 13 In addition to excessive procedural times for percutaneous radiofrequency ablation of 5 to 10 hours, 12,13 there are several procedure-related complications such as cardiac tamponade, stroke, thromboembolism, and pulmonary vein stenosis. 11-14
Recently, the concept of surgical elimination of anatomically determined left atrial "anchor" reentrant circuits by induction of contiguous left atrial lesion lines between the pulmonary veins and the mitral anulus with radiofrequency energy has been introduced. Under direct vision completeness of the lesion line has been verified, with short procedure times. 15 In this article we describe our experience and early and midterm outcomes in 234 patients with chronic AF who underwent intraoperative radiofrequency ablation of AF, either isolated or in combination with other cardiac procedures.
|
|
TopAbstractIntroductionResultsDiscussionAppendix: DiscussionReferences |
|---|
Surgical procedure
Patients were operated on through a median sternotomy (n = 101, 43.2%) or through a minimally invasive surgical approach through a right lateral minithoracotomy (n = 133, 56.8%). Categorizing all patients into groups determined by surgical procedure and approach, 3 groups were defined: intraoperative radiofrequency ablation as primary indication for operation and performed minimally invasively (group A, n = 74 patients), ablation and mitral valve surgery with minimally invasive technique or conventional technique (group B, n = 95), and ablation combined with other cardiac procedures in a conventional technique (group C, n = 65; Table 1).
|
In the minimally invasive group a right lateral minithoracotomy (4-6 cm) in the fourth intercostal space was performed and bypass was established by femorofemoral cannulation. For arterial cannulation a 16F to 20F arterial cannula was used (Baxter Healthcare Corporation, Edwards Division, Irvine, Calif). Venous drainage was achieved with a 22F femoral cannula (Heartport, Inc, Redwood City, Calif) and a 16F arterial cannula inserted in the right internal jugular vein (Baxter Edwards) with enhanced venous drainage with vacuum assistance. Direct aortic clamping was performed with a transthoracic clamp (Chitwood clamp; Scanlan International, St Paul, Minn) inserted percutaneously in the second intercostal space. Antegrade cold crystalloid cardioplegia or cold blood cardioplegia was applied for myocardial protection by puncture of the ascending aorta. After exposure of the left atrium, it was incised parallel to the interatrial groove anterior to the right pulmonary veins, thus allowing direct access to the mitral anulus as well as to the orifices of the pulmonary veins. No further atriotomy was performed, and the right atrium was not opened except in case of concomitant tricuspid valve repair. The left atrial appendage was not excised or ligated. Continuous carbon dioxide insufflation was used to evacuate air from the operative field.
Radiofrequency ablation (Figure 1)
|
Postoperative management and follow-up
After the operation all patients were monitored daily with 12-lead electrocardiographic recordings for the first 5 postoperative days. In addition, two 24-hour electrocardiographic recordings were performed for every patient. In cases of postoperative AF that occurred within 10 days after the operation, electric cardioversion was performed either alone or in combination with the administration of amiodarone, flecainide, or sotalol. Patients in stable sinus rhythm (as defined by the presence of a P wave) without additional antiarrhythmic therapy received anticoagulation for 3 months; all patients who were receiving additional antiarrhythmic drugs received anticoagulation for 6 months. Patients were evaluated on discharge and 6 months thereafter by a 12-lead electrocardiography and 24-hour Holter monitoring. Follow-up was considered complete for patients seen at the 6- and 12-month follow-up examinations. On the basis of these data, a 95% confidence interval (CI) was calculated.
Statistical analysis
Continuous variables are expressed as mean ± SD. A 95% CI for the probability of success was calculated by the Clopper-Pearson method for dichotomous data, which takes into account the number of examinations, thus yielding probability intervals for sinus rhythm at discharge and at 6 and 12 months' follow-up. Statistical calculations were performed with StatXact (release 4.0; Cytel Software Corporation, Cambridge, Mass).
|
Results |
|---|
|
TopAbstractIntroductionResultsDiscussionAppendix: DiscussionReferences |
|---|
Early recurrence of atrial fibrillation and perioperative arrhythmias
Perioperative atrial arrhythmias were observed in 143 patients (61.1%) as supraventricular tachyarrhythmia (n = 71, 30.3%), atypical flutter (n = 112, 47.9%), or both. A total of 133 patients were treated successfully with one or more cardioversions alone (56.8%) or in combination with amiodarone (n = 92, 39.3%), flecainide (n = 30, 12.8%), or sotalol (n = 21, 8.9%). Ninety (38.5%) patients had to be monitored for more than 3 days in the intermediate care unit because of unstable cardiac rhythms.
Discharge
Of the patients discharged (n = 224), sinus rhythm was established in 188 patients (83.9%); 19 patients (8.5%) were discharged with atypical flutter, and 17 patients (7.6%) were discharged with persisting AF.
In a comparison by groups, restoration of sinus rhythm was successful in 91.9% of cases in group A (n = 68), 76.8% of cases in group B (n = 73), and 72.3% of cases in group C (n = 47). In group A 1.4% of the patients (n = 1/74) were discharged with atypical flutter, as compared with 5.3% in group B (n = 5/95) and 6.2% in group C (n = 4/65). Atypical flutter was observed in 5.4% of patients in group A (n = 4/74), 12.6% of patients in group B (n = 12/95), and 4.6% of patients in group C (n = 3/65). In 23 cases (9.8%) a permanent pacemaker implantation was needed after the operation because of sinus bradycardia, with or without sinus arrest or atrioventricular dissociation.
Six months' and 12 months' follow-up (Table 2)
|
After 12 months 93.8% (15/16) of group A, 70.0% (30/43) of group B, and 61.9% (13/21) of group C were in sinus rhythm, respectively.
Sinus rhythm with intermittent AF or atypical flutter was observed in 6.3% (1/16) in group A, 2.3% (1/43) in group B, and 4.8% (1/21) in group C. Atypical flutter was observed in 7.0% (3/43) in group B and 4.8% (1/21) in group C. Twelve months' follow-up was complete in 80 of 88 patients (90.9%) with 58 patients still in sinus rhythm (72.5% [95% CI: 61.3%-83.2%]). One patient required an additional 2-chamber pacemaker implantation (0.4%) and 1 patient (0.4%) had a cerebral stroke during the follow-up period. Three patients had died after 12 months, 2 of unknown cause and 1 of a cerebral stroke.
Complications, morbidity, and mortality
Two patients (0.8%) required conversion from minithoracotomy to median sternotomy. Reexploration for bleeding was required in 18 patients (6.8%), and 6 patients required postoperative circulatory support such as intra-aortic balloon pumping (n = 5, 2.1%) or extracorporeal membrane oxygenation (n = 2, 0.8%). Two patients (0.8%) required reoperation within 5 days after the initial operation: 1 patient had mitral valve regurgitation after initial reconstruction and 1 patient had a prosthesis infection. Two patients (0.8%) had sternal infections, 1 patient (0.4%) showed perioperative ischemia caused by stenosis of the circumflex artery, which was successfully treated by angioplasty and stent implantation, and 3 patients (1.3%) had cerebral strokes after the operation. Three patients (1.2%) had atrioesophageal perforations, and 2 of them had successful reoperations. One patient (0.4%) died of severe cerebral infarction, and 1 patient (0.4%) had an inguinal infection after femorofemoral cannulation.
Mortality was 15 patients (6.4%); 10 patients (4.2%) died during postoperative hospitalization, with a mean hospitalization time of 33.8 days (range 10-96 days). Two patients (0.8%) died of adult respiratory distress syndrome, 1 patient died (0.4%) of pulmonary embolism, 3 patients (1.3%) died of sepsis, 2 patients (0.8%) died of low cardiac output, 1 patient (0.4%) died of stroke, and 1 patient (0.4%) died of unknown causes.
All deaths but 1 (of cerebral air embolism after atrioesophageal infarction) were related to the high-risk profile of the underlying cardiac disease and not to the intraoperative radiofrequency ablation procedure. There were no deaths among the patients treated for isolated chronic or paroxysmal AF. Atrioesophageal perforation was the only procedure-related complication, and in 1 case (0.4%) it was lethal.
|
Discussion |
|---|
|
TopAbstractIntroductionResultsDiscussionAppendix: DiscussionReferences |
|---|
16 in 1991 as a curative therapy for patients with chronic AF. Depending on inclusion criteria, restoration of sinus rhythm is possible for 65% to 93% of the patients. 6,17-19 Reported mortality for combined operations and the need for postoperative pacemaker implantation are in the range of 0% to 5% and 2% to 14%, respectively. 19 Several attempts have been made to develop simpler but equally effective surgical treatment strategies, but so far none has exceeded the good results of the original maze III procedure. 5,8,20
In 1997 Patwardhan and colleagues 21 reported the use of intraoperative radiofrequency coagulation to induce contiguous lesion lines to replace the right and left atrial incisions of the maze III procedure. A combined approach with surgical incisions and radiofrequency-induced linear lesions was introduced by Sie and coworkers, 22 reducing the operating time for the maze procedure. Melo and associates 23 used radiofrequency-induced contiguous left atrial lesion lines around the pulmonary veins for surgical pulmonary vein isolation and achieved restoration of sinus rhythm in 71% of their cases. A similar approach of surgical isolation of the pulmonary veins with cryoablation was recently reported by Sueda and colleagues. 24 At a mean follow-up of 8 months, 83% of their patients (n = 12) were in sinus rhythm.
Whereas these strategies have aimed at isolating the focus for AF, our strategy for intraoperative radiofrequency ablation of AF follows the concept of elimination of anatomically determined left atrial "anchor" reentrant circuits by induction of contiguous left atrial lesion lines between the pulmonary veins and the mitral anulus with radiofrequency energy. 25,26 This concept is based on the hypothesis that anatomically defined left atrial reentrant circuits are crucial for the perpetuation of AF. These circuits anchor around the pulmonary vein orifices when functional reentrant circuits have been extinguished, thereby ensuring maintenance of AF and preventing its termination. 27
An initial study (n = 12) demonstrated that a restricted approach of elimination of anatomically defined anchor reentrant circuits within the left atrium prevented chronic AF in more than 80% of patients with mitral valve disease and chronic AF. 27 Further modifications of the technique have allowed its routine application through a minimally invasive approach through a right anterolateral minithoracotomy, 28 which is currently the access of choice for isolated mitral valve surgery at our institution. 29,30 The patients included in this study represent an unselected group of patients with a variety of cardiac diseases who underwent intraoperative radiofrequency ablation, either alone or in combination with additional cardiac procedures. Morbidity, mortality, freedom from AF at early and midterm follow-up, and the need for postoperative pacemaker implantation are comparable to the results of the maze III procedure. Whereas the maze III procedure is a relatively rare operation (76 patients in a 5-year period at one institution 31 and 346 patients in a 12-year period at the leading center 32), the ease of application of intraoperative radiofrequency ablation allowed its use in 234 patients in a 2-year period, with about half of the patients operated on in a minimally invasive fashion. The avoidance of a sternotomy has largely increased patient acceptance of surgical treatment for isolated AF and is the major reason for increased patient referral for antiarrhythmic surgical treatment. Relative to the maze procedure, aortic crossclamp and cardiopulmonary bypass times are shorter, and postoperative diuretic treatment for atrial natriuretic peptide deficiency is not necessary. 33 The limited left atrial approach will, of course, not eliminate atrial flutter originating from the right atrium, as the maze procedure does. As our data in group A clearly demonstrate, however, this approach is highly effective to treat stand-alone AF. Postoperative atrial flutter was therefore not encountered as recurrence of AF among our patients and was subsequently treated successfully by catheter techniques in some cases.
There are, however, new procedure-related complications that require careful application of this technique. In 3 cases we found atrioesophageal fistulas that were seen after an initial uncomplicated recovery at postoperative intervals of 3 and 6 days, with repetitive neurologic deficits caused by multiple air embolisms in 2 patients. Both of the latter patients underwent reoperation for repair of the esophagus and left atrium. In another case sudden onset of upper gastrointestinal tract bleeding necessitated gastroscopy. After insufflation of carbon dioxide, massive cerebral air embolism occurred, from which the patient died. All other deaths (n = 9) were not procedure related. Although the exact mechanism of esophageal injury after intraoperative radiofrequency ablation of AF and subsequent transesophageal echocardiographic studies is still speculative, the most likely cause of this detrimental sequel is a thermal injury during radiofrequency application, in combination with mechanical trauma induced by the echocardiographic probes. In all cases a transesophageal echocardiography probe was in place before and 3 to 6 days after the operation to study left atrial contractility, and this may have caused additional mechanical irritation. Since the first complication occurred, we no longer leave the probe in the esophagus during ablation and have switched to transthoracic echocardiography during the early postoperative period. In addition, an isolating scrub is placed into the sinus obliquus pericardii behind the left atrial wall to prevent the passage of electric and thermal energy through the esophagus. Esophageal perforations have been observed by others with different radiofrequency catheter devices and also in some cases after transesophageal echocardiographic studies alone. This complication needs further investigation.
Several studies with percutaneous radiofrequency catheter ablation within the right atrium showed an extremely limited efficacy, indicating that induction of right atrial lesions is not sufficient to cure AF. The lesion geometries that have been applied percutaneously so far seem to be empirically derived, and no successful lesion geometry concept for percutaneous application has been validated. Failure to induce continuous lesion lines necessary for proper isolation has led to the poor results reported for catheter-based left atrial ablation. In addition to a disappointing 100% recurrence rate, complications of catheter-based interventions included cerebral infarction, tamponade necessitating immediate pericardiocentesis, retroperitoneal hematoma, and pneumothorax, as well as pericardial effusions and pacemaker implantations. 13
Because of the poor results of catheter-based interventions for the treatment of AF and in the light of the relatively small numbers of maze procedures that are performed, the concept of intraoperative radiofrequency ablation of AF seems to present a promising alternative. The necessity of avoiding procedure-related complications is obvious from the data presented here, but now that the mechanism of injury is known, means of prevention can be developed. The question whether different radiofrequency catheter probes or other energy sources, such as microwave and cryoablation, will demonstrate better surgical results requires future study.
|
Appendix: Discussion |
|---|
|
TopAbstractIntroductionResultsDiscussionAppendix: DiscussionReferences |
|---|
In addition, they are to be commended for advancing the development of this field in two important ways. First, they have demonstrated the feasibility of performing left atrial radiofrequency ablation as a primary procedure, with AF as the sole indication. It is interesting to note, in fact, that in this study ablations performed solely for AF actually resulted in higher midterm success rates than did ablations performed in combination with other cardiac operations. Second, by performing most of their procedures through small thoracotomy incisions, Mohr and associates have taken a critical step toward the ultimate goal of a totally minimally invasive surgical approach to the management of chronic AF.
I have several comments and questions, Dr Mohr. Your method of radiofrequency ablation is different from that used by our group and many others in that you do not circumferentially isolate the pulmonary veins and also do not electrically or mechanically exclude the left atrial appendage. As we have reported, we make a single encircling radiofrequency lesion around the pulmonary veins and a lesion to the mitral anulus but also make a lesion around the left atrial appendage and add a connecting line from this lesion to the pulmonary vein isolation line. We do this to exclude arrhythmogenic foci within the pulmonary veins and left atrial appendage, and also to prevent arrhythmias caused by reentrant conduction around the base of the appendage. Despite the differences in the techniques that we use, we have reported midterm success rates similar to those presented by you today for patients undergoing concomitant cardiac procedures such as mitral valve replacement. My first question is, how did you choose your lesion set, and which components of this set if any do you think are absolutely necessary for the reliable elimination of AF?
My second question relates to the handling of the left atrial appendage. In our experience, with careful inspection thrombus is often found within the appendage, even when it is not visualized by transesophageal echocardiography. For this reason we routinely ligate the appendage from within the atrium with a purse-string suture. Why have you chosen to leave the appendage open? And with regard to your patients who died of strokes, do you think it is possible that the source of embolization could have been the left atrial appendage?
My third question relates to two specific complications that occurred in your series: 3 atrioesophageal fistulas and 1 case of circumflex artery stenosis. Presumably, as you suggest, these injuries were induced by the radiofrequency probe. However, it seems unlikely to me that the application of radiofrequency energy controlled to a maximum temperature of 60°C to 65°C for only 20 seconds would cause this degree of damage, because most other authors have used higher target temperatures of 70°C to 80°C for much longer burn times, as long as 2 minutes, without significant injuries. Is it possible that the actual delivered temperature was higher than that recorded by the probe, as might be the case with continuous irrigation of the probe at the endocardial surface? Also, was too much pressure exerted on the probe in certain areas, perhaps because of inadequate exposure? To avoid these complications, we also routinely withdraw the transesophageal echocardiography probe at the time of radiofrequency delivery, and we also administer retrograde cardioplegia during radiofrequency application near the mitral anulus.
My next question is about your reference in your presentation to potential prophylactic use of this operation. You did not mention this in the article, but I presume that when you said prophylaxis, for instance, in patients having atrial septal defect closure, you meant that you actually applied this operation in patients who were not in AF at the time of surgery. If that is not what you meant, please clarify that.
Finally, although you mentioned that you performed echocardiographic evaluations to assess the effects of your operation on atrial transport function, you did not actually report those data. What were your findings with respect to atrial transport function in patients in whom you achieved electrocardiographic success?
I believe that this is a seminal contribution to this exciting field of surgical interest.
Dr Mohr. With respect to the prophylactic operations, these were patients who had AF but did not have severe symptoms. They were coming for an atrial septal defect closure or an autograft replacement and were in sinus rhythm, without AF at the time of the operation. So we considered this a prophylactic procedure. The same is true for the coronary artery bypass grafting operations.
The next question was about aortoesophageal fistulas. Actually, we are not the only ones who have observed aortoesophageal fistulas. They have also occurred with the other probe, the radiofrequency probe that your group is using. This has not been reported, but if you talk to some groups, you will discover that it has happened. I just wanted to draw attention to that. I truly believe that the radiofrequency itself may have some injury to the esophagus, with the mechanical push of the transesophageal echocardiographic probe, which was used after 1 week to evaluate left atrial contraction, perhaps finally causing the perforation. This is what I assume. I cannot tell you the reason.
With respect to the temperature, we have evaluated several radiofrequency probes, including the probe that you are using. The probe that you are using allows for a measurable temperature at the epicardium within 3 seconds up to 65°C and then it shuts off, whereas with the Boston Scientific probe it takes you up to 90 seconds to reach this epicardial temperature. This may well be why you do not have that effect on the esophagus. On the other hand, it does have an effect on continuous lines. If you look into the worldwide results with the other probe, they are worse than with our probe, because you are more likely to have a gap. At least we have found that in our laboratory.
The left atrial appendage is, as far as we can tell, a major part that helps in the contraction of the left atrium. If you cut it off, you will have a problem as with the Cox maze procedure in that you must continue diuretics all the time. You could sew the appendage closed, but in our study protocol we decided not to do so, so that we could measure the left atrial contractility also in the left atrial appendage.
To answer the question about the left atrial contractility, patients with normally sized left atria had normal left atrial contractility. If you remember Miller's scoring, it would be a score of 4. Among patients who had dilated left atria that were downsized, the left atrial contractility was relatively low at the beginning but had recovered after 3 to 6 months.
Our lesion sets did not include the left atrial appendage. I think that if you go to the electrophysiology meeting, it is the clear opinion of the cardiologists that the left atrial appendage does not play a role. Most of them localize the multifocal lesions in several pulmonary veins and alongside to the roof and the mitral valve anulus.
Finally, to answer the question about working only on the pulmonary veins alone on both sides, as has been described by some authors, I think that this misses an important connection to the mitral valve. This is why you cannot do the procedure epicardially. The connection to the mitral valve is essential, in our view.
Dr Niv Ad (Tel-Aviv, Israel). I have one question and a quick comment. Looking at your results, especially for the patients in whom the ablation was combined with mitral valve surgery, it is clear that your success rate in abolishing AF is significantly lower than the results reported by Cox and other big series from the United States. What do you think is the reason for this difference? Is it because you are ablating the left side only, or is it because of the use of radiofrequency, which is well known to be an unreliable option for the creation of transmural lesion?
With regard to your presentation of ablation lines in the left atrium, these are basically designed to isolate the pulmonary veins and are based on the experience of the cardiologists, rather then solid research. I think that it may be good enough to some extent for patients with paroxysmal AF, but not for patients with chronic AF and big atria.
Dr Mohr. I do not believe that this is the final answer to AF in general. I think that the Cox maze procedure is still the criterion standard. I do not think that we can yet answer the question of whether radiofrequency, cryoablation, or microwave is the best energy source. I think we can say, and I think you will agree, that we have to have a continuous transmural lesion. We also work with cryoablation, and the problem is that if you want to do it in a minimally invasive fashion, almost endoscopically, the cryoprobe does not allow you to go everywhere you want to, whereas radiofrequency allows you close contact everywhere, in every corner, and it is faster. Microwave may allow the same thing. I think that we all should look into the possibility of a new energy source that would help us to do it even faster and better.
The persistent late AF has been looked at by our cardiologists. It has never come from the right side but has always come from the left side. They tried to go back with catheter techniques to close the existing gaps that were present, and I think another reason is the large left atrium. We have to be more aggressive to downsize the atria in such patients. We follow Carpentier's technique to downsize the left atrium. In those cases in which we reduce the volume, we also close the left atrial appendage.
Dr D. Craig Miller (Stanford, Calif). How assured are you that you are getting a full-thickness lesion with these 20-second burns?
Dr Mohr. From the experimental work, we know that with this probe in 20 seconds we penetrate 1 cm, and within 5 seconds we reach, at the epicardium, the temperature of 60°C. That is why I truly believe that the esophageal lesion may have an impact with this technique. Now that we have isolated it, I hope that we will not see this problem anymore.
|
Footnotes |
|---|
|
References |
|---|
|
TopAbstractIntroductionResultsDiscussionAppendix: DiscussionReferences |
|---|
This article has been cited by other articles:
|
|
 |
|
  W. P. Beukema, H. T. Sie, A. R. Ramdat Misier, P. P. H.M. Delnoy, H. J.J. Wellens, and A. Elvan Intermediate to Long-Term Results of Radiofrequency Modified Maze Procedure as an Adjunct to Open-Heart Surgery Ann. Thorac. Surg., November 1, 2008; 86(5): 1409 - 1414. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. B. Rahmanian, J. G. Castillo, D. Mehta, D. H. Adams, and F. Filsoufi Epicardial Pulmonary Vein Isolation: A Long-Term Histologic and Imaging Animal Study Comparing Cryothermy Versus Radiofrequency Ann. Thorac. Surg., September 1, 2008; 86(3): 849 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Singh, A. d'Avila, S. K. Doshi, W. R. Brugge, R. A. Bedford, T. Mela, J. N. Ruskin, and V. Y. Reddy Esophageal Injury and Temperature Monitoring During Atrial Fibrillation Ablation Circ Arrhythmia Electrophysiol, August 1, 2008; 1(3): 162 - 168. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. T. McElderry, D. C. McGiffin, V. J. Plumb, K. Nanthakumar, A. E. Epstein, T. Yamada, and G. N. Kay Proarrhythmic Aspects of Atrial Fibrillation Surgery: Mechanisms of Postoperative Macroreentrant Tachycardias Circulation, January 15, 2008; 117(2): 155 - 162. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Eckart and L. M. Epstein Interventional Therapy for Atrial and Ventricular Arrhythmias Card. Surg. Adult, January 1, 2008; 3(2008): 1357 - 1374. [Full Text]
|
|
|
|
|
|
R. K. Voeller, R. B. Schuessler, and R. J. Damiano Jr. Surgical Treatment of Atrial Fibrillation Card. Surg. Adult, January 1, 2008; 3(2008): 1375 - 1394. [Full Text]
|
|
|
|
 |
|
 T. D. Bahnson Clinician's Commentary on Saremi et al Radiology, January 1, 2008; 246(1): 108 - 109. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Deneke, K. Khargi, B. Lemke, T. Lawo, M. Lindstaedt, A. Germing, T. Brodherr, L. Bosche, A. Mugge, A. Laczkovics, et al. Intra-operative cooled-tip radiofrequency linear atrial ablation to treat permanent atrial fibrillation Eur. Heart J., December 1, 2007; 28(23): 2909 - 2914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. El Oumeiri, C. Stefanidis, A. Sabry, M. Antoine, J.-M. De Smet, D. De Canniere, and J.-L. Jansens Long-term follow-up after endocardial radiofrequency modified Nitta procedure for concomitant atrial fibrillation treatment Interactive CardioVascular and Thoracic Surgery, June 1, 2007; 6(3): 319 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Stulak, J. A. Dearani, T. M. Sundt III, R. C. Daly, C. G.A. McGregor, K. J. Zehr, and H. V. Schaff Superiority of cut-and-sew technique for the Cox maze procedure: Comparison with radiofrequency ablation J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1022 - 1027. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Doty, D. B. Doty, K. W. Jones, J. H. Flores, M. Mensah, B. B. Reid, S. E. Clayson, G. Snow, E. Righter, and R. C. Millar Comparison of standard Maze III and radiofrequency Maze operations for treatment of atrial fibrillation J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 1037 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Martin-Suarez, B. Claysset, L. Botta, M. Ferlito, D. Pacini, C. Savini, G. Marinelli, and R. DiBartolomeo Surgery for atrial fibrillation with radiofrequency ablation: four years experience Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 71 - 76. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Gillinov Advances in Surgical Treatment of Atrial Fibrillation Stroke, February 1, 2007; 38(2): 618 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Bakir, F. P. Casselman, P. Brugada, P. Geelen, F. Wellens, I. Degrieck, F. Van Praet, Y. Vermeulen, R. De Geest, and H. Vanermen Current Strategies in the Surgical Treatment of Atrial Fibrillation: Review of the Literature and Onze Lieve Vrouw Clinic's Strategy Ann. Thorac. Surg., January 1, 2007; 83(1): 331 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K.E.W. Ballaux, G. S.C. Geuzebroek, N. M. van Hemel, J. C. Kelder, K. M.E. Dossche, J. M.P.G. Ernst, L. V.A. Boersma, E. F.D. Wever, A. B. de la Riviere, and J. J.A.M.T. Defauw Freedom from atrial arrhythmias after classic maze III surgery: A 10-year experience J. Thorac. Cardiovasc. Surg., December 1, 2006; 132(6): 1433 - 1440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Jeanmart, F. Casselman, R. Beelen, F. Wellens, I. Bakir, F. Van Praet, G. Cammu, Y. Degriek, Y. Vermeulen, and H. Vanermen Modified Maze During Endoscopic Mitral Valve Surgery: The OLV Clinic Experience Ann. Thorac. Surg., November 1, 2006; 82(5): 1765 - 1769. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Jahangiri, G. Weir, K. Mandal, I. Savelieva, and J. Camm Current strategies in the management of atrial fibrillation. Ann. Thorac. Surg., July 1, 2006; 82(1): 357 - 364. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Itoh, J. Kobayashi, K. Bando, K. Niwaya, O. Tagusari, H. Nakajima, S. Komori, and S. Kitamura The impact of mitral valve surgery combined with maze procedure. Eur. J. Cardiothorac. Surg., June 1, 2006; 29(6): 1030 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Barnett and N. Ad Surgical ablation as treatment for the elimination of atrial fibrillation: A meta-analysis J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1029 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Knaut, S. M. Tugtekin, S. G. Spitzer, F. Jung, and K. Matschke Intraoperative endocardial microwave ablation for treatment of permanent atrial fibrillation during coronary artery bypass surgery: 1-year follow-up. Europace, January 1, 2006; 8(1): 16 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. K. Mishra Do we need to further probe the utility of these (energy) probes? Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 127 - 128. [Full Text] [PDF]
|
|
|
|
 |
|
 E. Good, H. Oral, K. Lemola, J. Han, K. Tamirisa, P. Igic, D. Elmouchi, D. Tschopp, S. Reich, A. Chugh, et al. Movement of the Esophagus During Left Atrial Catheter Ablation for Atrial Fibrillation J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2107 - 2110. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Aupperle, N. Doll, T. Walther, P. Kornherr, C. Ullmann, H.-A. Schoon, and F. W. Mohr Ablation of atrial fibrillation and esophageal injury: Effects of energy source and ablation technique J. Thorac. Cardiovasc. Surg., December 1, 2005; 130(6): 1549 - 1554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Doukas, N. J. Samani, C. Alexiou, M. Oc, D. T. Chin, P. G. Stafford, L. L. Ng, and T. J. Spyt Left Atrial Radiofrequency Ablation During Mitral Valve Surgery for Continuous Atrial Fibrillation: A Randomized Controlled Trial JAMA, November 9, 2005; 294(18): 2323 - 2329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. M. Guiraudon, D. L. Jones, A. C. Skanes, D. Bainbridge, C. M. Guiraudon, S. M. Jensen, X. Yuan, M. Drangova, and T. M. Peters En Bloc Exclusion of the Pulmonary Vein Region in the Pig Using Off Pump, Beating, Intra-Cardiac Surgery: A Pilot Study of Minimally Invasive Surgery for Atrial Fibrillation Ann. Thorac. Surg., October 1, 2005; 80(4): 1417 - 1423. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H.-M. Tsao, M.-H. Wu, S. Higa, K.-T. Lee, C.-T. Tai, N.-W. Hsu, C.-Y. Chang, and S.-A. Chen Anatomic Relationship of the Esophagus and Left Atrium: Implication for Catheter Ablation of Atrial Fibrillation Chest, October 1, 2005; 128(4): 2581 - 2587. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sanchez-Quintana, J. A. Cabrera, V. Climent, J. Farre, M. C. de Mendonca, and S. Y. Ho Anatomic Relations Between the Esophagus and Left Atrium and Relevance for Ablation of Atrial Fibrillation Circulation, September 6, 2005; 112(10): 1400 - 1405. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ninet, X. Roques, R. Seitelberger, C. Deville, J. L. Pomar, J. Robin, O. Jegaden, F. Wellens, E. Wolner, C. Vedrinne, et al. Surgical ablation of atrial fibrillation with off-pump, epicardial, high-intensity focused ultrasound: Results of a multicenter trial J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 803 - 803. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kubota, S. Takamoto, A. Furuse, M. Sato, H. Endo, T. Fujiki, and K. Sudo Epicardial Maze Procedure on the Beating Heart With an Infrared Coagulator Ann. Thorac. Surg., September 1, 2005; 80(3): 1081 - 1086. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chaput, D. Bouchard, P. Demers, L. P. Perrault, R. Cartier, M. Carrier, P. Page, and M. Pellerin Conversion to sinus rhythm does not improve long-term survival after valve surgery: insights from a 20-year follow-up study Eur. J. Cardiothorac. Surg., August 1, 2005; 28(2): 206 - 210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Cummings, R. A. Schweikert, W. I. Saliba, J. D. Burkhardt, J. Brachmann, J. Gunther, V. Schibgilla, A. Verma, M. Dery, J. L. Drago, et al. Assessment of Temperature, Proximity, and Course of the Esophagus During Radiofrequency Ablation Within the Left Atrium Circulation, July 26, 2005; 112(4): 459 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Gillinov, P. M. McCarthy, E. H. Blackstone, J. Rajeswaran, G. Pettersson, J. F. Sabik III, L. G. Svensson, D. M. Cosgrove, K. M. Hill, G. V. Gonzalez-Stawinski, et al. Surgical ablation of atrial fibrillation with bipolar radiofrequency as the primary modality J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1322 - 1329. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Fayad, T. Le Tourneau, T. Modine, R. Azzaoui, P.-V. Ennezat, C. Decoene, G. Deklunder, and H. Warembourg Endocardial Radiofrequency Ablation During Mitral Valve Surgery: Effect on Cardiac Rhythm, Atrial Size, and Function Ann. Thorac. Surg., May 1, 2005; 79(5): 1505 - 1511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Golovchiner, A. Mazur, A. Kogan, B. Strasberg, Y. Shapira, M. Fridman, J. Kuzniec, B. A. Vidne, and E. Raanani Atrial Flutter After Surgical Radiofrequency Ablation of the Left Atrium for Atrial Fibrillation Ann. Thorac. Surg., January 1, 2005; 79(1): 108 - 112. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Fasol, J. Meinhart, and T. Binder A modified and simplified radiofrequency ablation in patients with mitral valve disease J. Thorac. Cardiovasc. Surg., January 1, 2005; 129(1): 215 - 217. [Full Text] [PDF]
|
|
|
|
|
|
G. Bolotin, A. P. Kypson, L. W. Nifong, and W. R. Chitwood Jr Robotically-Assisted Left Atrial Fibrillation Ablation and Mitral Valve Repair Through a Right Mini-Thoracotomy Ann. Thorac. Surg., October 1, 2004; 78(4): e63 - e64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Nguyen-Do, P. Bannon, and D. Y. Leung Coronary artery to the left atrial fistula after resection of atrial appendages Ann. Thorac. Surg., August 1, 2004; 78(2): e26 - e27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. S. Kabbani, H. Jamil, A. Hammoud, J. A. Hatab, F. Nabhani, R. Hariri, N. Sabbagh, and D. Ross The mitral pulmonary autograft: assessment at midterm Ann. Thorac. Surg., July 1, 2004; 78(1): 60 - 65. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Quader, P. M. McCarthy, A. M. Gillinov, J. M. Alster, D. M. Cosgrove III, B. W. Lytle, and E. H. Blackstone Does preoperative atrial fibrillation reduce survival after coronary artery bypass grafting? Ann. Thorac. Surg., May 1, 2004; 77(5): 1514 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Romano, D. S. Bach, F. D. Pagani, R. L. Prager, G. M. Deeb, and S. F. Bolling Atrial reduction plasty Cox maze procedure: extended indications for atrial fibrillation surgery Ann. Thorac. Surg., April 1, 2004; 77(4): 1282 - 1287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Kiaii, N. Doll, M. Kuehl, and F. W. Mohr Minimal invasive endoscopic resection of a giant left atrial appendage aneurysm Ann. Thorac. Surg., April 1, 2004; 77(4): 1437 - 1438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Doll, R. Meyer, T. Walther, and F. W. Mohr A new cryoprobe for intraoperative ablation of atrial fibrillation Ann. Thorac. Surg., April 1, 2004; 77(4): 1460 - 1462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Laczkovics, K. Khargi, and T. Deneke Esophageal perforation during left atrial radiofrequency ablation J. Thorac. Cardiovasc. Surg., December 1, 2003; 126(6): 2119 - 2120. [Full Text] [PDF]
|
|
|
|
|
|
N. Doll, B. B. Kiaii, A. M. Fabricius, J. Bucerius, P. Kornherr, R. Krakor, J. F. Gummert, T. Walther, and F. W. Mohr Intraoperative left atrial ablation (for atrial fibrillation) using a new argon cryocatheter: early clinical experience Ann. Thorac. Surg., November 1, 2003; 76(5): 1711 - 1715. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Schuetz, C.J. Schulze, K.K. Sarvanakis, H. Mair, H. Plazer, E. Kilger, B. Reichart, and S.M. Wildhirt Surgical treatment of permanent atrial fibrillation using microwave energy ablation: a prospective randomized clinical trial Eur. J. Cardiothorac. Surg., October 1, 2003; 24(4): 475 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Sonmez, E. Demirsoy, N. Yagan, M. Unal, H. Arbatli, D. Sener, T. Baran, and F. Ilkova A fatal complication due to radiofrequency ablation for atrial fibrillation: atrio-esophageal fistula Ann. Thorac. Surg., July 1, 2003; 76(1): 281 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ohtsuka, H. Kubota, Y. Suematsu, N. Motomura, and S. Takamoto Video-assisted transseptal cryoablation of left atrium in nonmitral cases J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1537 - 1538. [Full Text] [PDF]
|
|
|
|
 |
|
 H. T Sie, W. P Beukema, A. Elvan, and A. R Ramdat Misier New strategies in the surgical treatment of atrial fibrillation Cardiovasc Res, June 1, 2003; 58(3): 501 - 509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Doll, M. A. Borger, A. Fabricius, S. Stephan, J. Gummert, F. W. Mohr, J. Hauss, H. Kottkamp, and G. Hindricks Esophageal perforation during left atrial radiofrequency ablation: Is the risk too high? J. Thorac. Cardiovasc. Surg., April 1, 2003; 125(4): 836 - 842. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-F. Legare, K. J. Buth, R. C. Arora, D. A. Murphy, J. A. Sullivan, and G. M. Hirsch The dome of the left atrium: an alternative approach for mitral valve repair Eur. J. Cardiothorac. Surg., March 1, 2003; 23(3): 272 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vijay and J. P. Gold Late Complications of Cardiac Surgery Card. Surg. Adult, January 1, 2003; 2(2003): 521 - 537. [Full Text]
|
|
|
|
|
|
A. M. Gillinov, E. H. Blackstone, and P. M. McCarthy Atrial fibrillation: current surgical options and their assessment Ann. Thorac. Surg., December 1, 2002; 74(6): 2210 - 2217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Patwardhan, V. S. Lad, and V. Pai Esophageal injury during radiofrequency ablation for atrial fibrillation: Inherent safety of radiofrequency bipolar coagulation J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 642 - 643. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kumar, T. Athanasiou, and R. D. L Stanbridge Treatment of long-duration atrial fibrillation by modified maze procedure J R Soc Med, January 11, 2002; 95(11): 552 - 553. [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
